These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34470570)

  • 1. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment.
    Kaneko K; Ozawa N; Murashima A
    Immunol Med; 2022 Jun; 45(2):79-93. PubMed ID: 34470570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R; Qin L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric Anti-phospholipid Syndrome: State of the Art.
    Gerardi MC; Fernandes MA; Tincani A; Andreoli L
    Curr Rheumatol Rep; 2018 Aug; 20(10):59. PubMed ID: 30105597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
    Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
    Ernest JM; Marshburn PB; Kutteh WH
    Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Antiphospholipid Syndrome.
    Arachchillage DRJ; Pericleous C
    Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
    Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
    J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
    Andreoli L; Regola F; Caproli A; Crisafulli F; Fredi M; Lazzaroni MG; Nalli C; Piantoni S; Zatti S; Franceschini F; Tincani A
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI86-SI95. PubMed ID: 38320595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
    Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
    Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and Antiphospholipid Syndrome.
    Schreiber K; Hunt BJ
    Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
    Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
    Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
    Li XY; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.